Target intelligence / Profile preview

Non-Protein arginine methyltransferase 4 messenger RNAs (shRNA off-targets)

Molecular classification
Messenger RNA, Nucleic acid
01

Overview

The term "Non-PRMT4 mRNAs with partial complementarity to the PRMT4 shRNA seed region" refers to a collection of messenger RNAs that are unintentionally silenced during experiments using short hairpin RNAs (shRNAs) designed to target Protein Arginine Methyltransferase 4 (PRMT4), also known as CARM1. This phenomenon, known as the RNAi off-target effect, occurs because the 6-8 nucleotide seed sequence of the shRNA possesses partial complementarity to sequences within the 3' untranslated regions (UTRs) of various non-target transcripts (Jackson et al., 2003). When these shRNAs are introduced into cells, they can trigger the degradation or translational repression of these unintended mRNAs via the RNA-induced silencing complex (RISC), mimicking the action of endogenous microRNAs (Birmingham et al., 2006). In cancer research, where PRMT4 is studied for its role in transcriptional co-activation and cell proliferation, such off-target effects can induce phenotypic changes that are incorrectly attributed to PRMT4 knockdown. To ensure experimental validity, researchers often use control strategies like the "C911" mismatch shRNA to distinguish between true PRMT4-dependent effects and these technical artifacts (Buehler et al., 2012). Consequently, these mRNAs represent a significant challenge in target validation and functional genomics rather than being therapeutic targets themselves.

Other names
Non-PRMT4 mRNAs with partial complementarity to the PRMT4 shRNA seed regionRNAi off-target transcriptsSeed-matched off-targetsshRNA off-target effectsCARM1 shRNA off-targets
02

Mechanism of action

Unintended gene silencing via the RNA interference (RNAi) pathway, where the shRNA seed region (nucleotides 2-8) binds to complementary sequences in the 3' untranslated regions of non-target mRNAs, leading to their degradation or translational repression by the RISC complex.

03

Biological functions

Gene expression regulationRNA interference pathway substrate
04

Disease associations

Experimental artifact
05

Safety considerations

False positive results in functional genomicsMisinterpretation of gene essentialityOff-target toxicity in RNAi-based therapeutics
06

Interacting drugs

PRMT4-targeted short hairpin RNA

Beyond the preview

Go deeper on Non-Protein arginine methyltransferase 4 messenger RNAs (shRNA off-targets).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Non-Protein arginine methyltransferase 4 messenger RNAs (shRNA off-targets).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call